Alkermes Plc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Alkermes Plc. on February 14, 2018, covering events reported as of February 12, 2018. The filing addresses significant changes in corporate leadership and board composition.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on governance and personnel changes rather than financial performance.
Material Changes
- Resignation of President: Shane M. Cooke notified the Company of his resignation as President of Alkermes Plc. and Alkermes Pharma Ireland Limited, effective March 5, 2018.
- Board Expansion and Election: On February 14, 2018, the Board of Directors increased its size from eight to nine members and elected Shane M. Cooke as a Class III director, effective March 30, 2018.
- Director Term: Mr. Cooke's director term will expire at the 2020 annual general meeting of shareholders.
Guidance, Outlook, and Compensation
Mr. Cooke will receive an annual cash retainer and equity compensation for his board service, consistent with the "Director Compensation" section of the Company's 2017 Proxy Statement. He is scheduled to receive a new director grant and a pro-rated annual grant at the first regularly scheduled Board meeting he attends after his appointment. The Company will also enter into a deed of indemnification with Mr. Cooke. No financial guidance or operational outlook is provided in this filing.
Investor Verification Checklist
- Verify the effective dates of Mr. Cooke's resignation as President (March 5, 2018) and his appointment as a director (March 30, 2018).
- Review the 2017 Proxy Statement to confirm the specific terms of the cash retainer and equity compensation for directors.
- Confirm the appointment of a successor to the role of President, as this filing does not name a replacement.
- Check for any subsequent filings regarding the interim leadership structure between the resignation and the board appointment.